Related Experiment Video
Updated: May 7, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors
Wei Li1, Songpei Li, Koji Higai
1Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan.
Abstract:
Protein tyrosine phosphatase 1B (PTP1B) is a major negative regulator in insulin- and leptin-signaling cascades as well as a positive regulator in tumorigenesis, and much attention has been paid to PTP1B inhibitors as potential therapies for diabetes, obesity, and cancer. In the present study, the screening of a compound library of licorice flavonoids allowed for the discovery of several compounds, including licoagrone (3), licoagrodin (4), licoagroaurone (5), and isobavachalcone (6), as new PTP1B inhibitors. It was revealed that these compounds inhibit the activity of PTP1B in different modes and with different selectivities and that they exhibit different cellular activity in the insulin-signaling pathway. Glycybenzofuran (1), a competitive PTP1B inhibitor, showed both excellent inhibitory selectivity against PTP1B and cellular activity on the insulin-stimulated Akt phosphorylation level. The similarity of its action profiling in the insulin-signaling pathway suggested its potential as a new anti-insulin-resistant drug candidate.
Insights
New licorice flavonoids, including glycybenzofuran, show potential as PTP1B inhibitors. Glycybenzofuran demonstrates selective inhibition and cellular activity, suggesting its use as an anti-insulin-resistant drug candidate for diabetes and obesity.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Protein tyrosine phosphatase 1B (PTP1B) is a key regulator in insulin and leptin signaling pathways.
- PTP1B also plays a role in cancer development, making its inhibitors attractive therapeutic targets for diabetes, obesity, and cancer.
Purpose of the Study:
- To screen licorice flavonoids for novel PTP1B inhibitors.
- To evaluate the inhibitory mechanisms, selectivity, and cellular activity of identified compounds in the insulin-signaling pathway.
Main Methods:
- Screening of a licorice flavonoid compound library against PTP1B.
- Assays to determine inhibitory modes, selectivity, and cellular effects on insulin signaling.
- Analysis of Akt phosphorylation levels in response to insulin stimulation.
Main Results:
- Several licorice flavonoids, including licoagrone, licoagrodin, licoagroaurone, and isobavachalcone, were identified as new PTP1B inhibitors.
- These compounds exhibited varied inhibition modes, selectivities, and cellular activities.
- Glycybenzofuran, a competitive PTP1B inhibitor, displayed high selectivity and significant cellular activity in the insulin-signaling pathway, specifically on insulin-stimulated Akt phosphorylation.
Conclusions:
- Licorice flavonoids represent a promising source for novel PTP1B inhibitors.
- Glycybenzofuran's potent PTP1B inhibition and favorable cellular activity profile suggest its potential as a therapeutic candidate for combating insulin resistance.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Dipeptidyl Peptidase 4 Inhibitors
